Cite
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
MLA
Nelp, Micah T., et al. “Immune-Modulating Enzyme Indoleamine 2,3-Dioxygenase Is Effectively Inhibited by Targeting Its Apo-Form.” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 13, Mar. 2018, pp. 3249–54. EBSCOhost, https://doi.org/10.1073/pnas.1719190115.
APA
Nelp, M. T., Kates, P. A., Hunt, J. T., Newitt, J. A., Balog, A., Maley, D., Xiao Zhu, Abell, L., Allentoff, A., Borzilleri, R., Lewis, H. A., Zeyu Lin, Seitz, S. P., Chunhong Yan, & Groves, J. T. (2018). Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proceedings of the National Academy of Sciences of the United States of America, 115(13), 3249–3254. https://doi.org/10.1073/pnas.1719190115
Chicago
Nelp, Micah T., Patrick A. Kates, John T. Hunt, John A. Newitt, Aaron Balog, Derrick Maley, Xiao Zhu, et al. 2018. “Immune-Modulating Enzyme Indoleamine 2,3-Dioxygenase Is Effectively Inhibited by Targeting Its Apo-Form.” Proceedings of the National Academy of Sciences of the United States of America 115 (13): 3249–54. doi:10.1073/pnas.1719190115.